Aristotle Atlantic Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$12.9M |
| 2 |
Bank of America
BAC
|
+$9.62M |
| 3 |
Oracle
ORCL
|
+$8.51M |
| 4 |
CrowdStrike
CRWD
|
+$6.24M |
| 5 |
GE Aerospace
GE
|
+$4.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$15.9M |
| 2 |
Microsoft
MSFT
|
+$14.3M |
| 3 |
DexCom
DXCM
|
+$13.4M |
| 4 |
Apple
AAPL
|
+$13.3M |
| 5 |
Microchip Technology
MCHP
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.36% |
| 2 | Communication Services | 11.3% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Financials | 10.4% |
Similar funds
Aristotle Atlantic Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Aristotle Atlantic Partners held 97 positions worth $3.18B, down 1.1% from $3.22B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Aristotle Atlantic Partners withdrew a net $157M in Q4 2024, closing 7 positions and reducing 58 holdings. Its most notable exit was DexCom, an estimated $13.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 40% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Aristotle Atlantic Partners opened a new position in GE Aerospace worth $4.41M.
- Aristotle Atlantic Partners's largest Q4 2024 buy was GE Aerospace: 26,427 shares worth $4.41M.
- Aristotle Atlantic Partners added most to Eli Lilly in Q4 2024, an estimated $12.9M increase.
- Aristotle Atlantic Partners's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $15.9M.
- Aristotle Atlantic Partners fully exited DexCom in Q4 2024, selling an estimated $13.4M.
- Aristotle Atlantic Partners's ten largest holdings make up 53% of its $3.18B portfolio in Q4 2024.
- Aristotle Atlantic Partners opened 2 new positions and closed 7 in Q4 2024.
- Aristotle Atlantic Partners's portfolio value fell 1.1% quarter-over-quarter to $3.18B.
Based on Aristotle Atlantic Partners's 13F filing for Q4 2024, filed 14 Feb 2025.